Table 2.
Hazard Ratio (95% CI) | |||||
---|---|---|---|---|---|
Variable | Categories | Overall survival | p-value | Cancer specific survival | p-value |
Age | ±median | 1.69 (1.15–2.48) | 0.007 | 1.00 (0.62–1.64) | 0.97 |
Gender | female vs. male | 0.90 (0.59–1.26) | 0.6 | 0.58 (0.31–1.07) | 0.08 |
T-stage | T1/2 vs. T3/4 | 4.32 (2.93–6.37) | <0.0001 | 9.62 (5.20–17.77) | <0.0001 |
N-stage | N0 vs. N1/2 | 3.22 (1.68–6.19) | <0.0001 | 5.01 (2.50–10.20) | <0.0001 |
M-stage | M0 vs. M1 | 5.51 (3.59–8.47) | <0.0001 | 9.57 (5.65–16.19) | <0.0001 |
Nuclear Grade | G1/2 vs. G3/4 | 3.80 (2.52–5.72) | <0.0001 | 6.78 (4.13–11.13) | <0.0001 |
Tumor Necrosis | yes vs. no | 1.80 (1.24–2.60) | 0.002 | 2.81 (1.70–4.66) | <0.0001 |
Sarcomatoid Differentiation | yes vs. no | 4.60 (2.72–7.76) | <0.0001 | 7.36 (4.08–13.25) | <0.0001 |
Vascular Invasion | yes vs. no | 3.10 (2.13–4.50) | <0.0001 | 5.67 (3.39–9.50) | <0.0001 |
Perinephric Invasion | yes vs. no | 2.53(1.23–4.11) | 0.008 | 2.20 (1.00–4.84) | 0.5 |
Sinus Invasion | yes vs. no | 2.29 (1.46–3.58) | <0.0001 | 2.78 (1.59–4.85) | <0.0001 |
Wnt1 Score tumor | ±mean | 1.18 (0.81–1.73) | 0.4 | 0.95 (0.57–1.58) | 0.84 |
β-catenin Score membrane tumor | ±mean | 1.26 (0.84–1.89) | 0.27 | 1.35 (0.79–2.30) | 0.28 |
β-catenin Score cytoplasm tumor | ±mean | 1.75 (1.04–2.94) | 0.035 | 2.26 (1.20–4.27) | 0.012 |